Get a Quote

ATAZANAVIR SULFATE API | CAS 229975-97-7
CAS NO.: 229975-97-7
Chemical Formula: C38H52N6O7•H2SO4
Molecular Weight: 802.9300
DMF&GMP status: Please contact us for more details.
Description:
Atazanavir is an antiviral medication that prevents human immunodeficiency virus (HIV) cells from multiplying in your body.

Atazanavir is used with other medications to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Atazanavir is not a cure for HIV or AIDS.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
ATAZANAVIR SULFATECAPSULE; ORALEQ 100MG BASEATAZANAVIR SULFATETEVA PHARMS USA
ATAZANAVIR SULFATE CAPSULE; ORAL EQ 150MG BASE ATAZANAVIR SULFATE TEVA PHARMS USA
ATAZANAVIR SULFATE CAPSULE; ORAL EQ 200MG BASE ATAZANAVIR SULFATE TEVA PHARMS USA
ATAZANAVIR SULFATE CAPSULE; ORAL EQ 300MG BASE ATAZANAVIR SULFATE TEVA PHARMS USA
ATAZANAVIR SULFATE CAPSULE; ORAL EQ 150MG BASE REYATAZ BRISTOL MYERS SQUIBB
ATAZANAVIR SULFATE CAPSULE; ORAL EQ 200MG BASE REYATAZ BRISTOL MYERS SQUIBB
ATAZANAVIR SULFATE CAPSULE; ORAL EQ 300MG BASE REYATAZ BRISTOL MYERS SQUIBB
ATAZANAVIR SULFATE POWDER; ORAL EQ 50MG BASE/PACKET REYATAZ BRISTOL MYERS SQUIBB
ATAZANAVIR SULFATE; COBICISTAT TABLET; ORAL EQ 300MG BASE; 150MG EVOTAZ BRISTOL MYERS SQUIBB
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
584991120-Jun-17YYU - 167
6087383 21-Dec-18 Y Y  
8148374 3-Sep-29 Y Y U - 1279
5849911 20-Jun-17 Y Y U - 167
Exclusive Data
Exclusivity Code Exclusivity Expiration